Literature DB >> 8520364

Breast cancer and hormonal supplements in postmenopausal women. Increase in risk of breast cancer is small.

C J Mugglestone.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 8520364      PMCID： PMC2543701          DOI： 10.1136/bmj.311.7018.1505a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Breast cancer and hormonal supplements in postmenopausal women.

Authors:  K McPherson
Journal:  BMJ       Date:  1995-09-16

2.  Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy.

Authors:  M J Nachtigall; S W Smilen; R D Nachtigall; R H Nachtigall; L E Nachtigall
Journal:  Obstet Gynecol       Date:  1992-11       Impact factor: 7.661

3.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

Authors:  T L Bush; E Barrett-Connor; L D Cowan; M H Criqui; R B Wallace; C M Suchindran; H A Tyroler; B M Rifkind
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

4.  Decreased mortality in users of estrogen replacement therapy.

Authors:  B E Henderson; A Paganini-Hill; R K Ross
Journal:  Arch Intern Med       Date:  1991-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.